ORX:STO
Orexo AB
SEKÂ 0.88
arrow_upward
+1.27%(+0.011) 1D
Nov 13, 5:29:57 PM GMT+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ORX...
Open
SEKÂ 0.90
High
SEKÂ 0.90
Low
SEKÂ 0.83
Mkt. cap
306.65M
Avg. vol.
739.90K
Volume
1.15M
P/E ratio
0.06
52-wk high
SEKÂ 22.55
52-wk low
SEKÂ 0.80
EPS
SEKÂ 13.61
Shares outstanding
35.13M
No. of employees
55
Open
SEKÂ 0.90
High
SEKÂ 0.90
Low
SEKÂ 0.83
Mkt. cap
306.65M
Avg. vol.
739.90K
Volume
1.15M
P/E ratio
0.06
52-wk high
SEKÂ 22.55
52-wk low
SEKÂ 0.80
EPS
SEKÂ 13.61
Shares outstanding
35.13M
No. of employees
55
News stories
From web sources and news partners
Trefis
·
3 hours ago
S&P 500 Movers | Winners: CHTR, STE, GPN | Losers: AMD, DELL, CSCO
qz.com
·
13 hours ago
How much of the S&P 500 is Nvidia? Concentration explained
Advisor Perspectives
·
1 hour ago
S&P 500 Snapshot: Stocks Up 2.5% to Log Best Week Since August
Traders Union
·
19 hours ago
S&P 500 falls over 1% as selling pressure and cautious trading weigh ahead of inflation data
Profile
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
About Orexo AB
CEONikolaj Sørensen
Employees55
Founded1995
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteorexo.com